Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-05-10
1994-08-16
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514392, 548112, 548252, 5483235, A61K 31415, C07D25704, C07D23332, C07F 906
Patent
active
053387520
ABSTRACT:
##STR1## Substituted 4,5-diaryl-2-imidazolones of structure (I), in which each group AR is the same or different and is optionally substituted phenyl or optionally substituted heteroaryl; R.sup.1 is hydrogen, alkyl, optionally substituted phenyl or optionally substituted heteroaryl; n is 4 to 12; and X is 5-tetrazolyl, SO.sub.3 H, P(O)(OR).sub.2, P(O)(OH).sub.2 or P(O)(R)(OR) in which R is hydrogen acceptable salt thereof, processes for preparing them, pharmaceutical compositions containing them and their use in therapy, inter alia, in the treatment of cardiovascular disorders.
REFERENCES:
CA 116(25):255613h Preparation of . . . Agonists, Hickey et al., p. 792, 1992.
Cooper David G.
Hickey Deirdre M. B.
Jaxa-Chamiec Albert A.
Dinner Dara L.
Lee Mary C.
Lentz Edward T.
McKane Joseph K.
SK&F Laboratories Ltd.
LandOfFree
Substituted 2-imidazolone derivatives, their preparation and pha does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 2-imidazolone derivatives, their preparation and pha, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 2-imidazolone derivatives, their preparation and pha will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-952103